Printer Friendly

Comparing Norplant and Depo-Provera.

Comparing Norplant and Depo-Provera

In a study done in Singapore in 1988, 100 present and past users of Norplant and 100 present and past users of Depo Provera (an injectable progestin given every three months that thickens cervical mucus and often suppresses ovulation) were questioned about these methods of birth control. 69% of current Norplant users said they would continue using it, while only 31% of current DP users wanted to continue. 60% of current DP users said they intended to switch to Norplant in the future for the convenience; none of the Norplant users wanted to switch.

The most important disadvantage of both methods was reported to be increased menstrual spotting and bleeding. 56% of past users of Norplant said they intended to use the implant again in the future, while only 20% of DP users would do so again--and 56% of them intended to consider Norplant.

The researchers concluded that women favored Norplant over Depo Provera, mainly because of its longer duration of action.

--Reported in Women's Global Network for Reproductive Rights Newsletter #31, Oct-Dec 1989, p.48.
COPYRIGHT 1991 Association of Labor Assistants & Childbirth Educators
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:contraceptive implant vs. injectable progestin
Publication:Special Delivery
Article Type:Product/Service Evaluation
Date:Jun 22, 1991
Previous Article:Norplant: satisfaction and side-effects.
Next Article:"Female condom" being tested.

Related Articles
Norplant: satisfaction and side-effects.
Birth control, culture and the control of women.
Depo-Provera approved by FDA.
Norplant users detail pain, losses suffered from contraceptive.
Neurotoxicity of contraceptive implant.
Contraceptive concerns about HIV.
Infant homicide through contraception.
Norplant: no problem ... except that it's off the market. (FYI).
Contraceptive choices: new options in the U.S. market.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters